Position in DXCM
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,501,500
+$177,928 QoQ
Shares Held
22,294
+5.8% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#425
of 973 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DXCM Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026&PARTNERS holds $126,756,911 across 24 Medical Devices names. DXCM ranks #8 (1.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
602,718 | $54,690,631 | |
| 2 | MDT |
Medtronic plc
|
446,593 | $34,936,970 | |
| 3 | SYK |
Stryker Corp
|
63,614 | $20,028,231 | |
| 4 | BSX |
Boston Scientific Corp
|
59,560 | $2,542,020 | |
| 5 | ZBH |
Zimmer Biomet Holdings, Inc.
|
25,534 | $2,198,222 | |
| 6 | EW |
Edwards Lifesciences Corp
|
22,966 | $2,077,504 | |
| 7 | SNN |
Smith & Nephew PLC
|
56,661 | $1,632,403 | |
| 8 | DXCM |
Dexcom Inc
This page
|
22,294 | $1,501,500 |
All Filings in DXCM
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,501,500 | 22,294 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $1,323,572 | 21,076 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $960,904 | 14,478 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $1,473,583 | 21,899 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $1,898,557 | 21,750 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $1,565,206 | 22,920 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $1,149,285 | 14,778 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $799,049 | 11,919 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $1,079,037 | 9,517 | Shares | Sole | 2024-07-24 | |
| No filing history on record for this holder in this stock. | ||||||